Enzene Sees Tariff Exemptions For India, Front-Ends US Capacity

Enzene’s CEO Himanshu Gadgil anticipates exemptions for Indian products from US tariffs expected to be imposed on pharmaceuticals. In an interview ahead of the US Vice Premier’s India visit, he also talks about front-loading capacity at Enzene’s US plant and a change in its biosimilars strategy

Source : https://insights.citeline.com/